APA-referens

Liu, B., Wang, T., Wang, H., Zhang, L., Xu, F., Fang, R., . . . Ye, L. (2018). Oncoprotein HBXIP enhances HOXB13 acetylation and co-activates HOXB13 to confer tamoxifen resistance in breast cancer. J Hematol Oncol.

Chicago-stil citat

Liu, Bowen, et al. "Oncoprotein HBXIP Enhances HOXB13 Acetylation and Co-activates HOXB13 to Confer Tamoxifen Resistance in Breast Cancer." J Hematol Oncol 2018.

MLA-referens

Liu, Bowen, et al. "Oncoprotein HBXIP Enhances HOXB13 Acetylation and Co-activates HOXB13 to Confer Tamoxifen Resistance in Breast Cancer." J Hematol Oncol 2018.

Varning: dessa hänvisningar är inte alltid fullständigt riktiga.